Joel D Kaufman1,2,3,4. 1. Environmental Health Perspectives, National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, USA. 2. Department of Environmental & Occupational Health Sciences, University of Washington, Seattle, Washington, USA. 3. Department of Medicine, University of Washington, Seattle, Washington, USA. 4. Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Observational studies have associated a wide variety of health problems with biomass-derived household air pollution. However, previous high-profile clinical trials of improved cookstoves did not demonstrate significant reductions in adverse health outcomes in the primary prespecified intent-to-treat analyses.[1-3] A major concern about these trials is that the interventions used did not reduce exposures to cookstove-derived pollutants sufficiently to result in health improvements.[4] In this issue of Environmental Health Perspectives, Johnson et al. report that the Household Air Pollution Intervention Network (HAPIN) trial appears to have overcome the challenges involved in reducing exposures.[5] The next step is to demonstrate health improvements.Large clinical trials of environmental interventions in resource-poor countries are unusual for many reasons: They are difficult to conduct, expensive, and fraught with logistical challenges. They can also raise ethical concerns, including concerns about withholding interventions from the control group.[6] In the case of cooking-related exposures, prior clinical trials resulted in uneven results. The ensuing conversations focused on two issues. First, many participants did not exclusively or continually use novel cooking approaches, for a variety of structural, logistical, economic, or social reasons. Second, changing stove technologies without also changing the biomass fuel sources yielded only modest improvement in pollution, such that the intervention pollutant concentrations were not reduced deeply into the postulated “steep” part of the concentration–response relationship.[7]In 2015, the National Institutes of Health solicited applications for a large multisite clinical trial to assess whether a cookstove and fuel intervention to reduce household air pollutants in low- and middle-income countries would achieve improvements in health outcomes.[8] With additional support from the Bill & Melinda Gates Foundation, HAPIN was born. HAPIN investigators, with centers in India, Rwanda, Guatemala, and Peru, randomly assigned 3,200 pregnant women who used biomass cookstoves to either receive liquified petroleum gas stoves and fuel supplies or continue using their current stoves.[9-11] As primary outcomes, the trial sought to determine whether the intervention reduced low birth weight, prevented severe pneumonia incidence in infancy, prevented childhood stunting, and reduced blood pressure in older household members.The HAPIN trial began recruitment in May 2018, with data collection continuing through August 2021. The investigators encountered all the challenges that are typically expected for a large clinical trial of its type. However, the study was further complicated by the COVID-19 pandemic through a major portion of the period for collecting health outcome information.Nevertheless, the research team persevered, and the striking results reported by Johnson et al. demonstrate the effectiveness of their intervention in lowering pollutant concentrations. This study reflects not only the use of a much cleaner fuel than in prior large trials but also the efforts of the team to ensure adherence to the protocol and prevent “stacking” of stoves—the practice of continuing to use polluting biomass stoves in addition to the cleaner intervention device.[12] Average pollutant concentrations fell in the intervention group from at baseline to . Concentrations remained unchanged in the control homes. Reductions were consistent across the four sites and persisted through follow-up. Although these dramatic improvements did not achieve the concentrations set by the U.S. Environmental Protection Agency[13] and the World Health Organization[14] for ambient exposures, there is reason to believe they have moved exposures meaningfully down the hypothesized concentration–response relationship.Ambitious trials such as HAPIN, if successful, can accomplish many things. By using a robust experimental design, a well-conducted randomized clinical trial may convince those who question the importance of findings seen in observational research. It can tell us whether an intervention reduces exposures. It can answer questions about the health effects of the exposures of interest, including exposure–response relationships. It can inform us about the feasibility of interventions. It can investigate the barriers (technical, social, and behavioral) to interventions. Ultimately, and depending on the results, it can motivate investment of resources in public health interventions, setting the stage for implementation research and action based on the findings. Even as some have argued that randomized trials may not be necessary to understand environmental health effects,[15] a carefully designed and ethically conducted trial certainly can be an influential component of the evidence base.[16]The extraordinary efforts of the HAPIN investigative team have paid off with regard to identifying several opportunities. It clearly is possible to implement a clean cooking technology intervention in highly varied resource-poor environments on several continents—if you have the funds and tenacity to do so. We also now know that doing so will substantially reduce people’s exposure to pollutants over some period of time. Now the stage is set for the health analyses that will follow.
Authors: Kirk R Smith; John P McCracken; Martin W Weber; Alan Hubbard; Alisa Jenny; Lisa M Thompson; John Balmes; Anaité Diaz; Byron Arana; Nigel Bruce Journal: Lancet Date: 2011-11-12 Impact factor: 79.321
Authors: Michael A Johnson; Kyle Steenland; Ricardo Piedrahita; Maggie L Clark; Ajay Pillarisetti; Kalpana Balakrishnan; Jennifer L Peel; Luke P Naeher; Jiawen Liao; Daniel Wilson; Jeremy Sarnat; Lindsay J Underhill; Vanessa Burrowes; John P McCracken; Ghislaine Rosa; Joshua Rosenthal; Sankar Sambandam; Oscar de Leon; Miles A Kirby; Katherine Kearns; William Checkley; Thomas Clasen Journal: Environ Health Perspect Date: 2020-04-29 Impact factor: 9.031
Authors: Thomas Clasen; William Checkley; Jennifer L Peel; Kalpana Balakrishnan; John P McCracken; Ghislaine Rosa; Lisa M Thompson; Dana Boyd Barr; Maggie L Clark; Michael A Johnson; Lance A Waller; Lindsay M Jaacks; Kyle Steenland; J Jaime Miranda; Howard H Chang; Dong-Yun Kim; Eric D McCollum; Victor G Davila-Roman; Aris Papageorghiou; Joshua P Rosenthal Journal: Environ Health Perspect Date: 2020-04-29 Impact factor: 9.031
Authors: Ashlinn K Quinn; Kendra N Williams; Lisa M Thompson; Steven A Harvey; Ricardo Piedrahita; Jiantong Wang; Casey Quinn; Ajay Pillarisetti; John P McCracken; Joshua P Rosenthal; Miles A Kirby; Anaité Diaz Artiga; Gurusamy Thangavel; Ghislaine Rosa; J Jaime Miranda; William Checkley; Jennifer L Peel; Thomas F Clasen Journal: Int J Environ Res Public Health Date: 2021-11-29 Impact factor: 3.390
Authors: Michael Johnson; Ajay Pillarisetti; Ricardo Piedrahita; Kalpana Balakrishnan; Jennifer L Peel; Kyle Steenland; Lindsay J Underhill; Ghislaine Rosa; Miles A Kirby; Anaité Díaz-Artiga; John McCracken; Maggie L Clark; Lance Waller; Howard H Chang; Jiantong Wang; Ephrem Dusabimana; Florien Ndagijimana; Sankar Sambandam; Krishnendu Mukhopadhyay; Katherine A Kearns; Devan Campbell; Jacob Kremer; Joshua P Rosenthal; William Checkley; Thomas Clasen; Luke Naeher Journal: Environ Health Perspect Date: 2022-09-16 Impact factor: 11.035
Authors: Kevin Mortimer; Chifundo B Ndamala; Andrew W Naunje; Jullita Malava; Cynthia Katundu; William Weston; Deborah Havens; Daniel Pope; Nigel G Bruce; Moffat Nyirenda; Duolao Wang; Amelia Crampin; Jonathan Grigg; John Balmes; Stephen B Gordon Journal: Lancet Date: 2016-12-07 Impact factor: 79.321
Authors: Kendra N Williams; Lisa M Thompson; Zoe Sakas; Mayari Hengstermann; Ashlinn Quinn; Anaité Díaz-Artiga; Gurusamy Thangavel; Elisa Puzzolo; Ghislaine Rosa; Kalpana Balakrishnan; Jennifer Peel; William Checkley; Thomas F Clasen; J Jaime Miranda; Joshua P Rosenthal; Steven A Harvey Journal: BMJ Open Date: 2020-09-29 Impact factor: 2.692
Authors: Richard T Burnett; C Arden Pope; Majid Ezzati; Casey Olives; Stephen S Lim; Sumi Mehta; Hwashin H Shin; Gitanjali Singh; Bryan Hubbell; Michael Brauer; H Ross Anderson; Kirk R Smith; John R Balmes; Nigel G Bruce; Haidong Kan; Francine Laden; Annette Prüss-Ustün; Michelle C Turner; Susan M Gapstur; W Ryan Diver; Aaron Cohen Journal: Environ Health Perspect Date: 2014-02-11 Impact factor: 9.031